Literature DB >> 8693455

Lung bioavailability of generic and innovator salbutamol MDIs.

H Chrystyn, S A Corlett, V Silkstone.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8693455      PMCID: PMC1090505          DOI: 10.1136/thx.51.6.658

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  1 in total

1.  Determination of the relative bioavailability of salbutamol to the lung following inhalation.

Authors:  M Hindle; H Chrystyn
Journal:  Br J Clin Pharmacol       Date:  1992-10       Impact factor: 4.335

  1 in total
  7 in total

Review 1.  Methods to identify drug deposition in the lungs following inhalation.

Authors:  H Chrystyn
Journal:  Br J Clin Pharmacol       Date:  2001-04       Impact factor: 4.335

Review 2.  Deposition and effects of inhaled corticosteroids.

Authors:  Stephen P Newman
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  Early lung absorption profile of non-CFC salbutamol via small and large volume plastic spacer devices.

Authors:  B J Lipworth; D J Clark
Journal:  Br J Clin Pharmacol       Date:  1998-07       Impact factor: 4.335

4.  Lung delivery of non-CFC salbutamol via small volume metal spacer and large volume plastic spacer devices compared with an open vent jet nebulizer.

Authors:  B J Lipworth; D J Clark
Journal:  Br J Clin Pharmacol       Date:  1998-02       Impact factor: 4.335

5.  Effects of airway calibre on lung delivery of nebulised salbutamol.

Authors:  B J Lipworth; D J Clark
Journal:  Thorax       Date:  1997-12       Impact factor: 9.139

6.  Effect of electrostatic charge in plastic spacers on the lung delivery of HFA-salbutamol in children.

Authors:  J Anhøj; H Bisgaard; B J Lipworth
Journal:  Br J Clin Pharmacol       Date:  1999-03       Impact factor: 4.335

7.  Pharmacokinetics and systemic beta2-adrenoceptor-mediated responses to inhaled salbutamol.

Authors:  S J Fowler; B J Lipworth
Journal:  Br J Clin Pharmacol       Date:  2001-04       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.